Showing 161 - 180 results of 104,188 for search '(( 15 mean decrease ) OR ( 5 ((step decrease) OR (((we decrease) OR (a decrease)))) ))', query time: 0.42s Refine Results
  1. 161
  2. 162
  3. 163
  4. 164
  5. 165

    SLE T cells display more genes with increased rather than decreased expression. by Sean J. Bradley (823158)

    Published 2015
    “…<p><b>A)</b> Distribution of expression stratified at the 1.5-, 2-fold and q<0.05 CUFFDIFF2 significance levels. …”
  6. 166

    Juvenile demyelination leads to a substantial decrease in potassium currents in PV interneurons of the PFC. by Sara Hijazi (21656615)

    Published 2025
    “…<p><b>A.</b> Representative traces of potassium currents evoked with 10 mV potential steps from −70mV to +60 mV in PFC PV interneurons from control (black) and cuprizone (red) mice. …”
  7. 167
  8. 168

    Image 5_Exploration of the diagnostic and prognostic roles of decreased autoantibodies in lung cancer.tif by Ying Ye (72583)

    Published 2025
    “…Diagnosing malignant small lung nodules (≤3cm) in CT scans remains a challenge in clinical practice.</p>Methods<p>In this study, we applied the HuProt array and the bioinformatics analysis to assess the diagnostic values of the decreased autoantibodies in lung cancers.…”
  9. 169
  10. 170

    Structure of YOLOv5s-SBC. by Zhongjian Xie (4633099)

    Published 2024
    “…YOLOv5s-SBC also increased mAP by 4.0% compared to the original YOLOv5s, with parameters decreased by 65%, model size decreased by 60%, and FLOPs decreased to 15.3G. …”
  11. 171

    Phenethyl isothiocyanate activates leptin signaling and decreases food intake by Miho Yagi (5921252)

    Published 2018
    “…Leptin is a weight-reducing hormone produced by adipose tissue, which decreases food intake <i>via</i> hypothalamic leptin receptors (Ob-Rb) and the Janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3) signaling pathway. …”
  12. 172

    A summary of the included study characteristics. by Zahra Tajik (20752452)

    Published 2025
    “…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”
  13. 173
  14. 174
  15. 175
  16. 176

    Multicenter Phase 2 Trial of Sirolimus for Tuberous Sclerosis: Kidney Angiomyolipomas and Other Tumors Regress and VEGF- D Levels Decrease by Sandra L. Dabora (206838)

    Published 2011
    “…Kidney angiomyolipomas regrew when sirolimus was discontinued but responses tended to persist if treatment was continued after week 52. We observed regression of brain tumors (SEGAs) in 7/11 cases (26% mean decrease in diameter), regression of liver angiomyolipomas in 4/5 cases (32.1% mean decrease in longest diameter), subjective improvement in facial angiofibromas in 57%, and stable lung function in women with TSC/LAM (n = 15). …”
  17. 177
  18. 178
  19. 179
  20. 180